Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

Phase 2
2(50.0%)
Phase 1
1(25.0%)
N/A
1(25.0%)
4Total
Phase 2(2)
Phase 1(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04266275Phase 2Not Yet Recruiting

Topical Curcumin for HPV Related Cervical Disease

Role: lead

NCT06628570Not ApplicableRecruiting

Screening Strategies Among High-risk Populations for Anal Cancer

Role: lead

NCT06626230Phase 1Recruiting

Safety of Anal Curcumin

Role: lead

NCT02944578Phase 2Terminated

Topical Curcumin for Precancer Cervical Lesions

Role: lead

All 4 trials loaded